← Eichor
Condition: Other Gastrointestinal Disorders Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Other Gastrointestinal Disorders

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

AnovaOS Network Powered Patient Registry
Phase N/A · 1 location(s) · Anova Enterprises, Inc · NCT05013944Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Phase 1/Phase 2 · 27 location(s) · Institut de Recherches Internationales Servier · NCT05786924A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harbor
Phase 2 · 31 location(s) · Allist Pharmaceuticals, Inc. · NCT06008288Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT04892849An International Study on Pediatric Patients With Rare Tumors.
Phase N/A · 1 location(s) · Azienda Ospedaliera di Padova · NCT07072143A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Canc
Phase 1 · 1 location(s) · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06500052A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
Phase 2 · 1 location(s) · Ausper Biopharma Co., Ltd. · NCT07069569Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers
NA · 1 location(s) · Institute of Oncology Ljubljana · NCT06060990A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced So
Phase 1 · 30 location(s) · Coherus Oncology, Inc. · NCT06657144Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
Phase 1/Phase 2 · 87 location(s) · Betta Pharmaceuticals Co., Ltd. · NCT04930432CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With
Phase 2 · 1 location(s) · Northwestern University · NCT05733000The European NAFLD Registry
Phase N/A · 37 location(s) · Newcastle University · NCT04442334BSGM to Evaluate Patients With GI Symptoms
Phase N/A · 5 location(s) · Children's Hospital of Philadelphia · NCT05880199Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT03454035A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone
Phase 2 · 1 location(s) · Fujian Shengdi Pharmaceutical Co., Ltd. · NCT06425341Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Phase 1/Phase 2 · 6 location(s) · Revolution Medicines, Inc. · NCT07397338A Study of HQP1351 in Patients With GIST or Other Solid Tumors
Phase 1 · 6 location(s) · Ascentage Pharma Group Inc. · NCT03594422Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Phase 1 · 9 location(s) · RayzeBio, Inc. · NCT07165132A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cance
Phase 1/Phase 2 · 1 location(s) · Shanghai Hengrui Pharmaceutical Co., Ltd. · NCT06474468Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations
Phase N/A · 1 location(s) · Qilu Hospital of Shandong University · NCT06041009Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients Wi
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06364410Biobank for Cholestatic Liver Diseases.
Phase N/A · 1 location(s) · Mayo Clinic · NCT03445585Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00451022Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenoca
Phase 2 · 2 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07102901Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) for Achalasia
NA · 1 location(s) · Medical University of Vienna · NCT02518542HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors
Phase 2 · 21 location(s) · Hansoh BioMedical R&D Company · NCT06112704HEARTS Trial for Thoracic Cancers
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT07132918Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Te
Phase 1/Phase 2 · 105 location(s) · Boehringer Ingelheim · NCT06324357HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
Phase 1 · 1 location(s) · Shanghai Ruiliyuan Biotechnology Co., Ltd. · NCT06515314
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.